Pharmacological mechanisms of berberine against triple negative breast cancer: Integration of network pharmacology and experimental validation
Objective: Berberine (BBR) has garnered attention for its potential effectiveness against triple-negative breast cancer (TNBC). To further understand its pharmacological mechanisms, this study employed a combination of network pharmacology analysis and experimental verification for providing insight...
Saved in:
| Main Authors: | Tian Qin, Kaixuan Liu, Yushi Yang, Jinjin Huang, Tengxiang Chen, Yinhui Jiang, Shu Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Phytomedicine Plus |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667031324001684 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01) -
Pharmacological properties and therapeutic potential of berberine: a comprehensive review
by: Ke-Qin Fan, et al.
Published: (2025-08-01) -
Enhancement of antitumor effects of berberine chloride with a copper(II) complex against human triple negative breast cancer: In vitro studies
by: Duaa R. Alajroush, et al.
Published: (2024-12-01) -
Berberine chloride inhibits proliferation and angiogenesis in triple-negative breast cancer by down-regulating HIF-1α/VEGF/Ang pathway
by: Nishmaa Sulthan Mohideen, et al.
Published: (2025-05-01) -
Network Pharmacology, Molecular Docking, and Molecular Dynamics Analysis of Honokiol against Triple-negative Breast Cancer
by: Hassan H. Alhassan
Published: (2024-12-01)